Development of a multi-targeted chemotherapeutic approach based on G-quadruplex stabilisation and carbonic anhydrase inhibition

References

• Bochman ML, Paeschke K, Zakian VA. DNA secondary structures: stability and function of G-quadruplex structures. Nat Rev Genet. 2012;13(11):770–780.
   PubMed Web of Science ®Google Scholar
• Spiegel J, Adhikari S, Balasubramanian S. The structure and function of DNA G-Quadruplexes. Trends Chem. 2020;2(2):123–136.
   PubMedGoogle Scholar
• Teng FY, Jiang ZZ, Guo M, Tan XZ, Chen F, Xi XG, Xu Y, Quadruplex G. DNA: a novel target for drug design. Cell Mol. Life Sci. 2021; 78:6557–6583.
   PubMed Web of Science ®Google Scholar
• Marsico G, Chambers VS, Sahakyan AB, McCauley P, Boutell JM, Antonio MD, Balasubramanian S. Whole genome experimental maps of DNA G-quadruplexes in multiple species. Nucleic Acids Res. 2019;47(8):3862–3874.
   PubMed Web of Science ®Google Scholar
• Verma A, Yadav VK, Basundra R, Kumar A, Chowdhury S. Evidence of genome-wide G4 DNA-mediated gene expression in human cancer cells. Nucleic Acids Res. 2009;37(13):4194–4204.
   PubMed Web of Science ®Google Scholar
• Balasubramanian S, Hurley LH, Neidle S. Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? Nat Rev Drug Discov. 2011;10(4):261–275.
   PubMed Web of Science ®Google Scholar
• Romano F, Di Porzio A, Iaccarino N, Riccardi G, Di Lorenzo R, Laneri S, Pagano B, Amato J, Randazzo A. G-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting. Expert Opin. Ther. Pat. 2023;2023:1–29.
   Google Scholar
• Santos T, Salgado GF, Cabrita EJ, Cruz C. G-Quadruplexes and their ligands: biophysical methods to unravel G-Quadruplex/Ligand Interactions. Pharmaceuticals. 2021;14(8):769.
   Web of Science ®Google Scholar
• Pirota V, Stasi M, Benassi A, Doria F. Chapter Six: an overview of quadruplex ligands: their common features and chemotype diversity. In: Stephen Neidle, editor. Annual reports in medicinal chemistry. London (UK): Academic Press, 54, 2020, p. 163–196.
   Google Scholar
• Sanchez-Martin V, Soriano M, Garcia-Salcedo JA. Quadruplex ligands in cancer therapy. Cancers. 2021;13(13):3156.
   PubMed Web of Science ®Google Scholar
• Sun ZY, Wang XN, Cheng SQ, Su XX, Ou TM. Developing Novel G-Quadruplex Ligands: from Interaction with nucleic acids to interfering with nucleic acid-protein interaction. Molecules. 2019;24(3):396.
   PubMed Web of Science ®Google Scholar
• Alcaro S, Musetti C, Distinto S, Casatti M, Zagotto G, Artese A, Parrotta L, Moraca F, Costa G, Ortuso F, et al. Identification and characterization of new DNA G-quadruplex binders ­selected by a combination of ligand and structure-based virtual screening approaches. J Med Chem. 2013;56(3):843–855.
   PubMed Web of Science ®Google Scholar
• Alcaro S, Artese A, Iley JN, Missailidis S, Ortuso F, Parrotta L, Pasceri R, Paduano F, Sissi C, Trapasso F, et al. Rational design, synthesis, biophysical and antiproliferative evaluation of fluorenone derivatives with DNA G-quadruplex binding properties. ChemMedChem. 2010;5(4):575–583.
   PubMed Web of Science ®Google Scholar
• Mendes E, Cadoni E, Carneiro F, Afonso MB, Brito H, Lavrado J, Dos Santos DJVA, Vítor JB, Neidle S, Rodrigues CMP, et al. Combining 1,3-Ditriazolylbenzene and quinoline to discover a new G-Quadruplex-interactive small molecule active against cancer stem-like cells. ChemMedChem. 2019;14(14):1325–1328.
   PubMed Web of Science ®Google Scholar
• Di Porzio A, Galli U, Amato J, Zizza P, Iachettini S, Iaccarino N, Marzano S, Santoro F, Brancaccio D, Carotenuto A, et al. Synthesis and characterization of Bis-Triazolyl-pyridine derivatives as noncanonical DNA-interacting compounds. Int J Mol Sci. 2021;22(21):11959.
   PubMed Web of Science ®Google Scholar
• Kharel P, Becker G, Tsvetkov V, Ivanov P. Properties and biological impact of RNA G-quadruplexes: from order to turmoil and back. Nucleic Acids Res. 2020;48(22):12534–12555.
   PubMed Web of Science ®Google Scholar
• Dumas L, Herviou P, Dassi E, Cammas A, Millevoi S. G-Quadruplexes in RNA Biology: recent advances and future directions. Trends Biochem. Sci. 2021;46(4):270–283.
   PubMed Web of Science ®Google Scholar
• Bugaut A, Balasubramanian S. 5'-UTR RNA G-quadruplexes: translation regulation and targeting. Nucleic Acids Res. 2012;40(11):4727–4741.
   PubMed Web of Science ®Google Scholar
• Marzano S, Pagano B, Iaccarino N, Di Porzio A, De Tito S, Vertecchi E, Salvati E, Randazzo A, Amato J. Targeting of telomeric repeat-containing RNA G-Quadruplexes: from screening to biophysical and biological characterization of a new hit compound. Int J Mol Sci. 2021;22(19):10315.
   PubMed Web of Science ®Google Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat. Rev. Drug Discov. 2011; 10:767–777.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Supuran CT. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018). Expert Opin Ther Pat. 2018; 28:729–740.
   PubMed Web of Science ®Google Scholar
• A Study of SLC-0111 and gemcitabine for metastatic pancreatic ductal cancer in subjects positive for CAIX (SLC-0111-17-01) [accessed 2024 Jan 15]. https://clinicaltrials.gov/ct2/show/NCT03450018.
   Google Scholar
• Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature. 2019;575(7782):299–309.
   PubMed Web of Science ®Google Scholar
• Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, Shu Y. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157.
   PubMed Web of Science ®Google Scholar
• Jaaks P, Coker EA, Vis DJ, Edwards O, Carpenter EF, Leto SM, Dwane L, Sassi F, Lightfoot H, Barthorpe S, et al. Effective drug combinations in breast, colon and pancreatic cancer cells. Nature. 2022;603(7899):166–173.
   PubMed Web of Science ®Google Scholar
• Zhou J, Jiang X, He S, Jiang H, Feng F, Liu W, Qu W, Sun H. Rational design of multitarget-directed ligands: strategies and emerging paradigms. J Med Chem. 2019;62(20):8881–8914.
   PubMed Web of Science ®Google Scholar
• Costantino L, Barlocco D. Challenges in the design of multitarget drugs against multifactorial pathologies: a new life for medicinal chemistry? Future Med Chem. 2013;5(1):5–7.
   PubMed Web of Science ®Google Scholar
• Gilad Y, Gellerman G, Lonard DM, O’Malley BW. Drug combination in cancer treatment-from cocktails to conjugated combinations. Cancers. 2021;13(4):669.
   PubMed Web of Science ®Google Scholar
• Yao L, Mustafa N, Tan EC, Poulsen A, Singh P, Duong-Thi MD, Lee JXT, Ramanujulu PM, Chng WJ, Yen JJY, et al. Design and synthesis of ligand efficient dual inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) based on Ruxolitinib and Vorinostat. J Med Chem. 2017;60(20):8336–8357.
   PubMed Web of Science ®Google Scholar
• Andreucci E, Ruzzolini J, Peppicelli S, Bianchini F, Laurenzana A, Carta F, Supuran CT, Calorini L. The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy. J. Enzyme Inhib Med Chem. 2019;34(1):117–123.
   PubMed Web of Science ®Google Scholar
• Sarnella A, Ferrara Y, Auletta L, Albanese S, Cerchia L, Alterio V, De Simone G, Supuran CT, Zannetti A. Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion. J Exp Clin Cancer Res. 2022; 41:122.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Ceruso M, Bua S, Lomelino CL, Andring JT, McKenna R, Lanzi C, Sgambellone S, Pecori R, Matucci R, et al. Discovery of β-adrenergic receptors blocker-carbonic anhydrase inhibitor hybrids for multitargeted antiglaucoma therapy. J Med Chem. 2018;61(12):5380–5394.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Trallori E, Singh S, Lomelino CL, Bartolucci G, Di Cesare Mannelli L, Ghelardini C, McKenna R, Gratteri P, Supuran CT. 4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase Isoforms IX and XII showing hypoxia-enhanced antiproliferative profiles. J Med Chem. 2018;61(23):10860–10874.
   PubMed Web of Science ®Google Scholar
• Bua S, Lucarini L, Micheli L, Menicatti M, Bartolucci G, Selleri S, Di Cesare Mannelli L, Ghelardini C, Masini E, Carta F, et al. Bioisosteric development of multitarget nonsteroidal anti-inflammatory drug-carbonic anhydrases inhibitor hybrids for the management of rheumatoid arthritis. J Med Chem. 2020;63(5):2325–2342.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Supuran CT. Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. Expert Opin Drug Discov. 2019; 14:1175–1197.
   PubMed Web of Science ®Google Scholar
• Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A, Kyle A, Auf Dem Keller U, Leung S, Huntsman D, et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res. 2011;71(9):3364–3376.
   PubMed Web of Science ®Google Scholar
• Bhowmik D, Kumar GS. Recent advances in nucleic acid binding aspects of berberine analogs and implications for drug design. Mini Rev. Med. Chem. 2016; 16:104–119.
   PubMed Web of Science ®Google Scholar
• Dickerhoff J, Brundridge N, McLuckey SA, Yang D. Berberine molecular recognition of the parallel MYC G-Quadruplex in solution. J Med Chem. 2021;64(21):16205–16212.
   PubMed Web of Science ®Google Scholar
• Wang KB, Liu Y, Li J, Xiao C, Wang Y, Gu W, Li Y, Xia YZ, Yan T, Yang MH, et al. Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine. Nat Commun. 2022;13(1):6016.
   PubMed Web of Science ®Google Scholar
• Bazzicalupi C, Ferraroni M, Bilia AR, Scheggi F, Gratteri P. The crystal structure of human telomeric DNA complexed with berberine: an interesting case of stacked ligand to G-tetrad ratio higher than 1:1. Nucleic Acids Res. 2013;41(1):632–638.
   PubMed Web of Science ®Google Scholar
• Ferraroni M, Bazzicalupi C, Papi F, Fiorillo G, Guamán-Ortiz LM, Nocentini A, Scovassi AI, Lombardi P, Gratteri P. Solution and solid-state analysis of binding of 13-substituted berberine analogues to human telomeric G-quadruplexes. Chem. Asian J. 2016; 11:1107–1115.
   PubMed Web of Science ®Google Scholar
• Ma Y, Ou TM, Hou JQ, Lu YJ, Tan JH, Gu LQ, Huang ZS. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc. Bioorg Med Chem. 2008;16(16):7582–7591.
   PubMed Web of Science ®Google Scholar
• Wang ZC, Wang J, Chen H, Tang J, Bian AW, Liu T, Yu LF, Yi Z, Yang F. Synthesis and anticancer activity of novel 9,13-disubstituted berberine derivatives. Bioorg Med Chem Lett. 2020;30(2):126821.
   PubMed Web of Science ®Google Scholar
• Kacprzak K, Skiera I, Piasecka M, Paryzek Z. Alkaloids and isoprenoids modification by Copper(I)-Catalyzed Huisgen 1,3-Dipolar Cycloaddition (Click Chemistry): toward new functions and molecular architectures. Chem Rev. 2016;116(10):5689–5743.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Ferraroni M, Carta F, Ceruso M, Gratteri P, Lanzi C, Masini E, Supuran CT. Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations. J Med Chem. 2016;59(23):10692–10704.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Carta F, Ceruso M, Bartolucci G, Supuran CT. Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII. Bioorg Med Chem. 2015;23(21):6955–6966.
   PubMed Web of Science ®Google Scholar
• Jin X, Yan TH, Yan L, Li Q, Wang RL, Hu ZL, Jiang YY, Sun QY, Cao YB. Design, synthesis, and anticancer activity of novel berberine derivatives prepared via CuAAC "click" chemistry as potential anticancer agents. Drug Des Devel Ther. 2014; 8:1047–1059.
   PubMed Web of Science ®Google Scholar
• Becher J, Berdnikova DV, Ihmels H, Stremmel C. Synthesis and investigation of quadruplex-DNA-binding, 9-O-substituted berberine derivatives. Beilstein J Org Chem. 2020; 16:2795–2806.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. J Biol Chem. 1971;246(8):2561–2573.
   PubMed Web of Science ®Google Scholar
• Pagano B, Cosconati S, Gabelica V, Petraccone L, De Tito S, Marinelli L, La Pietra V, di Leva FS, Lauri I, Trotta R, et al. State-of-the-art methodologies for the discovery and characterization of DNA G-quadruplex binders. Curr Pharm Des. 2012;18(14):1880–1899.
   PubMed Web of Science ®Google Scholar
• Iaccarino N, Cheng M, Qiu D, Pagano B, Amato J, Di Porzio A, Zhou J, Randazzo A, Mergny JL. Effects of sequence and base composition on the CD and TDS Profiles of i-DNA. Angew Chem Int Ed Engl. 2021;60(18):10295–10303.
   PubMed Web of Science ®Google Scholar
• Dhamodharan V, Harikrishna S, Bhasikuttan AC, Pradeepkumar PI. Topology specific stabilization of promoter over telomeric G-quadruplex DNAs by bisbenzimidazole carboxamide derivatives. ACS Chem Biol. 2015;10(3):821–833.
   PubMed Web of Science ®Google Scholar
• De Cian A, Guittat L, Kaiser M, Saccà B, Amrane S, Bourdoncle A, Alberti P, Teulade-Fichou MP, Lacroix L, Mergny JL. Fluorescence-based melting assays for studying quadruplex ligands. Methods. 2007;42(2):183–195.
   PubMed Web of Science ®Google Scholar
• Campbell NH, Karim NH, Parkinson GN, Gunaratnam M, Petrucci V, Todd AK, Vilar R, Neidle S. Molecular basis of structure-activity relationships between salphen metal complexes and human telomeric DNA quadruplexes. J Med Chem. 2012;55(1):209–222.
   PubMed Web of Science ®Google Scholar
• Parkinson GN, Ghosh R, Neidle S. Structural basis for binding of porphyrin to human telomeres. Biochemistry. 2007;46(9):2390–2397.
   PubMed Web of Science ®Google Scholar
• Micco M, Collie GW, Dale AG, Ohnmacht SA, Pazitna I, Gunaratnam M, Reszka AP, Neidle S. Structure-based design and evaluation of naphthalene diimide G-quadruplex ligands as telomere targeting agents in pancreatic cancer cells. J Med Chem. 2013;56(7):2959–2974.
   PubMed Web of Science ®Google Scholar
• Collie GW, Promontorio R, Hampel SM, Micco M, Neidle S, Parkinson GN. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands. J Am Chem Soc. 2012;134(5):2723–2731.
   PubMed Web of Science ®Google Scholar
• Nicoludis JM, Miller ST, Jeffrey PD, Barrett SP, Rablen PR, Lawton TJ, Yatsunyk LA. Optimized end-stacking provides specificity of N-methyl mesoporphyrin IX for human telomeric G-quadruplex DNA. J Am Chem Soc. 2012;134(50):20446–20456.
   PubMed Web of Science ®Google Scholar
• Russo Krauss I, Ramaswamy S, Neidle S, Haider S, Parkinson GN. structural insights into the quadruplex-duplex 3’ interface formed from a telomeric repeat: a potential molecular target. J Am Chem Soc. 2016;138(4):1226–1233.
   PubMed Web of Science ®Google Scholar
• Guarra F, Marzo T, Ferraroni M, Papi F, Bazzicalupi C, Gratteri P, Pescitelli G, Messori L, Biver T, Gabbiani C. Interaction of a gold(i) dicarbene anticancer drug with human telomeric DNA G-quadruplex: solution and computationally aided X-ray diffraction analysis. Dalton Trans. 2018;47(45):16132–16138.
   PubMed Web of Science ®Google Scholar
• Cirri D, Bazzicalupi C, Ryde U, Bergmann J, Binacchi F, Nocentini A, Pratesi A, Gratteri P, Messori L. Computationally enhanced X-ray diffraction analysis of a gold(III) complex interacting with the human telomeric DNA G-quadruplex. Unravelling non-unique ligand positioning. Int J Biol Macromol. 2022; 211:506–513.
   PubMed Web of Science ®Google Scholar
• Papi F, Ferraroni M, Rigo R, Da Ros S, Bazzicalupi C, Sissi C, Gratteri P. Role of the Benzodioxole Group in the interactions between the natural alkaloids chelerythrine and coptisine and the human telomeric G-Quadruplex DNA. A multiapproach investigation. J Nat Prod. 2017;80(12):3128–3135.
   PubMed Web of Science ®Google Scholar
• Wang KB, Dickerhoff J, Yang D. Solution structure of ternary complex of berberine bound to a dGMP-Fill-In Vacancy G-Quadruplex formed in the PDGFR-β promoter. J Am Chem Soc. 2021;143(40):16549–16555.
   PubMed Web of Science ®Google Scholar
• Pastorek J, Pastoreková S, Callebaut I, Mornon JP, Zelník V, Opavský R, Zat’ovicová M, Liao S, Portetelle D, Stanbridge EJ. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene. 1994;9:2877–2888.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55–63.
   PubMed Web of Science ®Google Scholar
• Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, Das BC. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer. 2011;10(1):39.
   PubMed Web of Science ®Google Scholar
• Pang YN, Liang YW, Feng TS, Zhao S, Wu H, Chai YS, Lei F, Ding Y, Xing DM, Du LJ. Transportation of Berberine into HepG2, Hela and SY5Y cells: a correlation to its anti-cancer effect. PLoS One. 2014;9(11):e112937.
   PubMed Web of Science ®Google Scholar
• Biffi G, Tannahill D, McCafferty J, Balasubramanian S. Quantitative visualization of DNA G-quadruplex structures in human cells. Nat Chem. 2013;5(3):182–186.
   PubMed Web of Science ®Google Scholar
• Gavathiotis E, Heald RA, Stevens MFG, Searle MS. Drug recognition and stabilisation of the parallel-stranded DNA Quadruplex d(TTAGGGT)4 containing the human telomeric repeat. J Mol Biol. 2003;334(1):25–36.
   PubMed Web of Science ®Google Scholar
• Pacchiano F, Carta F, McDonald PC, Lou Y, Vullo D, Scozzafava A, Dedhar S, Supuran CT. Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J Med Chem. 2011;54(6):1896–1902.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Hilliard G, Ferguson T, Millhorn DE. Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha. J Biol Chem. 2003;278(18):15911–15916.
   PubMed Web of Science ®Google Scholar
• Coviello V, Marchi B, Sartini S, Quattrini L, Marini AM, Simorini F, Taliani S, Salerno S, Orlandi P, Fioravanti A, et al. 1,2-Benzisothiazole derivatives bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and cell proliferation under hypoxic conditions. J Med Chem. 2016;59(13):6547–6552.
   PubMed Web of Science ®Google Scholar
• Shen J, Varshney D, Simeone A, Zhang X, Adhikari S, Tannahill D, Balasubramanian S. Promoter G-quadruplex folding precedes transcription and is controlled by chromatin. Genome Biol. 2021;22(1):143.
   PubMed Web of Science ®Google Scholar
• Batie M, Frost J, Frost M, Wilson JW, Schofield P, Rocha S. Hypoxia induces rapid changes to histone methylation and reprograms chromatin. Science. 2019;363(6432):1222–1226.
   PubMed Web of Science ®Google Scholar
• Kirmes I, Szczurek A, Prakash K, Charapitsa I, Heiser C, Musheev M, Schock F, Fornalczyk K, Ma D, Birk U, et al. A transient ischemic environment induces reversible compaction of chromatin. Genome Biol. 2015;16(1):246.
   PubMedGoogle Scholar
• Bonardi A, Nocentini A, Bua S, Combs J, Lomelino C, Andring J, Lucarini L, Sgambellone S, Masini E, McKenna R, et al. sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand/isoform matching and selectivity of action. J Med Chem. 2020;63(13):7422–7444.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Alterio V, Bua S, Micheli L, Esposito D, Buonanno M, Bartolucci G, Osman SM, ALOthman ZA, Cirilli R, et al. Phenyl(thio)phosphon(amid)ate benzenesulfonamides as potent and selective inhibitors of human carbonic anhydrases II and VII counteract allodynia in a mouse model of oxaliplatin-induced neuropathy. J Med Chem. 2020;63(10):5185–5200.
   PubMed Web of Science ®Google Scholar
• Amato J, Pagano A, Cosconati S, Amendola G, Fotticchia I, Iaccarino N, Marinello J, De Magis A, Capranico G, Novellino E, et al. Discovery of the first dual G-Triplex/G-quadruplex stabilizing compound: a new opportunity in the targeting of G-Rich DNA structures? Biochim Biophys Acta Gen Subj. 2017; 1861:1271–1280.
   PubMed Web of Science ®Google Scholar
• Pagano B, Amato J, Iaccarino N, Cingolani C, Zizza P, Biroccio A, Novellino E, Randazzo A. Looking for efficient G-Quadruplex ligands: evidence for selective stabilizing properties and telomere damage by drug-like molecules. ChemMedChem. 2015;10(4):640–649.
   PubMed Web of Science ®Google Scholar
• Amato J, Pagano A, Capasso D, Di Gaetano S, Giustiniano M, Novellino E, Randazzo A, Pagano B. Targeting the BCL2 gene promoter G-Quadruplex with a new class of furopyridazinone-based molecules. ChemMedChem. 2018;13(5):406–410.
   PubMed Web of Science ®Google Scholar
• Amato J, Miglietta G, Morigi R, Iaccarino N, Locatelli A, Leoni A, Novellino E, Pagano B, Capranico G, Randazzo A. Monohydrazone based G-Quadruplex selective ligands induce DNA damage and genome instability in human cancer cells. J Med Chem. 2020;63(6):3090–3103.
   PubMed Web of Science ®Google Scholar
• Campbell NH, Parkinson GN. Crystallographic studies of quadruplex nucleic acids. Methods. 2007;43(4):252–263.
   PubMed Web of Science ®Google Scholar
• Kabsch W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr. D Biol. Crystallogr. 2010; 66:133–144.
   PubMed Web of Science ®Google Scholar
• Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D. 1997; 53:240–255.
   PubMed Web of Science ®Google Scholar
• Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AG, McCoy A, et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 2011; 67:235–242.
   PubMed Web of Science ®Google Scholar
• Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 2010;66:486–501.
   PubMed Web of Science ®Google Scholar